Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 6ZGI | P0DTC2 | Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation | |
| 6ZHD | P0DTC2 | H11-H4 bound to Spike | |
| 6ZLR | P0DTC2 | Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex. | |
| 7BEM | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 scFv | |
| 7BNM | P0DTC2 | Closed conformation of D614G SARS-CoV-2 spike protein | |
| 7BNN | P0DTC2 | Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD | |
| 7BYR | P0DTC2 | BD23-Fab in complex with the S ectodomain trimer | |
| 7C2L | P0DTC2 | S protein of SARS-CoV-2 in complex bound with 4A8 | |
| 7CDI | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD | |
| 7CDJ | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD | |
| 7CZV | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B | |
| 7D0B | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B | |
| 7D30 | P0DTC2 | Structure of sybody MR17-SR31 fusion in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) | |
| 7DEO | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7DX4 | P0DTC2 | The structure of FC08 Fab-hA.CE2-RBD complex | |
| 7DX7 | P0DTC2 | Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound) | |
| 7E3L | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7EB0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2 | |
| 7JMO | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04 | |
| 7JMP | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 | |
| 7JMW | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab | |
| 7JV4 | P0DTC2 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) | |
| 7JV6 | P0DTC2 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | |
| 7JVA | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | |
| 7JVC | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | |
| 7JW0 | P0DTC2 | SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment | |
| 7JWY | P0DTC2 | Structure of SARS-CoV-2 spike at pH 4.5 | |
| 7JX3 | P0DTC2 | Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology | |
| 7JZL | P0DTC2 | SARS-CoV-2 spike in complex with LCB1 (2RBDs open) | |
| 7JZM | P0DTC2 | SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) | |
| 7JZN | P0DTC2 | SARS-CoV-2 spike in complex with LCB3 (2RBDs open) | |
| 7JZU | P0DTC2 | SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) | |
| 7K43 | P0DTC2 | SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment | |
| 7K45 | P0DTC2 | SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains) | |
| 7K4N | P0DTC2 | SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment | |
| 7K8M | P0DTC2 | Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102 | |
| 7K8S | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1) | |
| 7K8T | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2) | |
| 7K8U | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104 | |
| 7K8V | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110 | |
| 7K8W | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119 | |
| 7K8X | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1) | |
| 7K8Y | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2) | |
| 7K8Z | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135 | |
| 7K90 | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144 | |
| 7K9Z | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52 | |
| 7KDH | P0DTC2 | SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | |
| 7KEB | P0DTC2 | SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
| 7KFW | P0DTC2 | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab) | |
| 7KFX | P0DTC2 | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-C2 Fab) |
